Khan, Shaheer
Carvajal, Richard D.
Article History
First Online: 28 July 2020
Compliance with Ethical Standards
:
: Shaheer Khan does not have any potential conflicts of interest to disclose. Richard D. Carvajal has received compensation from Bristol-Myers Squibb, Castle Biosciences, Compugen, Foundation Medicine, Immunocore, I-Mab, Incyte Corporation, Merck, Roche/Genentech, PureTech Health, Sanofi Genzyme, Sorrento Therapeutics, Aura Biosciences, Chimeron Bio, Rgenix, Amgen, Novartis, Pfizer, AstraZeneca, Bellicum Pharmaceuticals, Plexxikon, Mirati Therapeutics, MacroGenics, Corvus Pharmaceuticals, Bayer, Eli Lilly, and Astellas for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.